Pathstone Holdings
MRVI icon

Pathstone Holdings’s Maravai LifeSciences MRVI Stock Holding History

Pathstone Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,608
Closed -$41.1K – 2276
2025
Q1 		$41.1K Buy
18,608
+8,343
+81% +$33K ﹤0.01% 2185
2024
Q4 		$55.9K Sell
10,265
-1,803
-15% -$11.6K ﹤0.01% 2259
2024
Q3 		$100K Buy
+12,068
New +$104K ﹤0.01% 2237
2024
Q2 		– Sell
-10,132
Closed -$87.8K – 2356
2024
Q1 		$87.8K Buy
+10,132
New +$68.5K ﹤0.01% 2231

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.53B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Pathstone Holdings's MRVI Position: Q2 2025 in Review

Pathstone Holdings sold out of Maravai LifeSciences (MRVI) in Q2 2025, closing a stake of 18,608 shares — an estimated $41.1K sold.

Pathstone Holdings first reported a position in MRVI in Q1 2024 and held it in 4 quarters. The position peaked at $100K in Q3 2024. 150 funds tracked by Wall St. Rank hold MRVI as of Q2 2025.

  • Pathstone Holdings reported no remaining Maravai LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 18,608 Maravai LifeSciences shares in Q2 2025, an estimated $41.1K.
  • Pathstone Holdings first reported a position in Maravai LifeSciences in Q1 2024 and held it in 4 quarters.
  • Pathstone Holdings's Maravai LifeSciences position peaked at $100K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.